$GEVO

Ryan Christopher Michael sold $50K of GEVO

Ryan Christopher Michael (President & COO) sold 35,196 shares of Gevo, Inc. (GEVO) at $1.43 on 2026-06-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Ryan Christopher Michael
Published Jun 15, 2026, 9:19 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 15, 2026, 9:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$GEVO
Neutral
medium confidence
Mentioned
$GEVO
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GEVONeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price ($1.4252/share), and that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

This provides a concrete insider ownership change but lacks a fundamental catalyst, so trading impact is likely limited.

03

What to watch

Traders may overweight insider selling; the article provides no accompanying operational or financial catalyst (earnings, guidance, contracts) to connect to fundamentals.

Relevance 2/10Novelty 5/10Timing: Filed 2026-06-15; transaction dated 2026-06-12

Background

The article is an SEC Form 4 insider transaction disclosure for Gevo, Inc.

Company-level read

Ticker impact

$GEVONeutralMedium confidence
Context

Gevo insider Ryan Christopher Michael (President & COO) sold 35,196 shares in an open-market transaction on 2026-06-12 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this disclosure; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a disclosed insider sale with a pre-arranged 10b5-1 plan, which typically reduces interpretive value for directional trading.

Market effects

No sector-wide read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations; any dip could be overdone.

Key entities

  • Gevo, Inc.

    Company whose officer insider transaction is disclosed on SEC Form 4.

  • Ryan Christopher Michael

    President & COO who sold 35,196 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GEVOMedAI 8/10

Gevo (GEVO) Q2 2026 Earnings Call Transcript

Gevo (GEVO) reported Q2 2026 revenue of $47 million, up 7% year over year, and non-GAAP adjusted EBITDA of $11 million. Full-year 2026 adjusted EBITDA guidance is now above $60 million. The company targets $70 million of 45Z tax credit monetization in 2026 and recorded a $176 million noncash impairment tied to exiting its ATJ-60 project.

$GEVOHigh

Gevo, Inc. (GEVO): Results of Operations and Financial Condition

Gevo, Inc. (GEVO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Gevo Reports Second Quarter Results and Raises Financial Expectations for Full-Year 2026 ENGLEWOOD, Colo. – August 6, 2026 – Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels, chemicals and carbon management, today announced its financial results for the second

$GEVOMedAI 8/10

Why Is Gevo (GEVO) Stock Rocketing Higher Today

Gevo (NASDAQ: GEVO) shares rose about 7.5% after the company said it expects 2026 non-GAAP Adjusted EBITDA to be more than double prior estimates. Gevo attributed the upgrade to new carbon pathways, higher production, and cost reductions, and it announced Todd Werpy, Ph.D., joining its board. The stock is volatile and trades at $1.68.